Analyses of the functional effects of USP39 inhibition revealed that this approach significantly suppressed ovarian cancer cell growth and migration, induced cell cycle G2/M phase arrest, and impaired clone formation. This evidence concerns the gene USP39 and ovarian carcinoma.